JNSW-10032

N/A

Report date: 2025/01/26 18:06:25
NME

Base Information

Drug NameJNSW-10032
Drug Alias NameJNSW-10032
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Basal CellLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Qiuwen Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Qiuwen Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Basal CellLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A